Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Retained Earnings (2011 - 2026)

Palatin Technologies' (PTN) quarterly Retained Earnings came in at $473.7 million in Q1 2026, up 203.68% on a YoY basis from $156.0 million in Q1 2025, and little changed quarter-over-quarter from $473.1 million in Q4 2025.

Analysis

Palatin Technologies (PTN) Retained Earnings (2011 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Retained Earnings for 15 consecutive years, with $473.7 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Retained Earnings rose 203.68% year-over-year to $473.7 million; the trailing twelve-month figure through Mar 2026 stood at $473.7 million (up 203.68% YoY), and the FY2025 full-year result was -$459.1 million, down 3.92% from the prior year.
  • Retained Earnings steadied at $473.7 million in Q1 2026 per PTN's latest filing, from $473.1 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $473.7 million in Q1 2026 and bottomed at -$459.1 million in Q2 2025.
  • Historically, Retained Earnings has averaged $21.0 million across 5 years, with a median of $401.0 million in 2022.
  • The widest YoY moves for Retained Earnings: up 204.66% in 2025, down 205.04% in 2025.
  • Over 5 years, Retained Earnings stood at $413.9 million in 2022, then tumbled by 202.7% to -$425.1 million in 2023, then fell by 6.34% to -$452.0 million in 2024, then surged by 204.66% to $473.1 million in 2025, then advanced by 0.12% to $473.7 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered $473.7 million, $473.1 million, and $454.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 558.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -6.33 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 20.97 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 5.13 Bn
10 Palatin Technologies 46.98 Mn 46.98 Mn - 473.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 473.67 Mn
Dec 31, 2025 473.11 Mn
Sep 30, 2025 454.78 Mn
Jun 30, 2025 -459.07 Mn
Mar 31, 2025 -456.84 Mn
Dec 31, 2024 -452.03 Mn
Sep 30, 2024 -449.59 Mn
Jun 30, 2024 -441.77 Mn
Mar 31, 2024 434.93 Mn
Dec 31, 2023 -425.08 Mn
Sep 30, 2023 -421.38 Mn
Jun 30, 2023 -412.03 Mn
Mar 31, 2023 414.30 Mn
Dec 31, 2022 413.91 Mn
Sep 30, 2022 404.61 Mn
Jun 30, 2022 404.17 Mn
Mar 31, 2022 400.99 Mn
Dec 31, 2021 400.47 Mn
Sep 30, 2021 399.56 Mn
Jun 30, 2021 401.35 Mn